Integer (ITGR) Stock Price, News & Analysis

Company Overview

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech. The Advanced Delivery segment focuses on drug delivery systems, including wearable injectors, pen and autoinjectors, prefilled syringes and inhalation devices. The MedTech segment serves cardiovascular, neuromodulation, diagnostic and orthopedic markets by manufacturing implantable components, surgical instruments, integrated assemblies and aftermarket services such as repair, reprocessing and technical support.

Tracing its heritage to the medical device operations of Greatbatch, Inc., the company formally rebranded as Integer in late 2014 to underscore its focus on outsourced device solutions. Integer operates manufacturing and R&D centers across North America, Europe and Asia-Pacific, supporting a global customer base from concept through post-market lifecycle management.

The company is led by President and Chief Executive Officer Robert A. Pollock, whose leadership has emphasized operational excellence and strategic growth in high-value medtech segments. Through targeted investments in advanced technology platforms and capacity expansion, Integer aims to deliver integrated solutions tailored to evolving regulatory requirements and end-user needs.

Key Stats

• Today's Range: $105.00 to $106.91
• 50-Day Range: $105.44 to $122.92
• 52-Week Range: $104.93 to $146.36
• Volume: 118,189 shs
• Average Volume: 468,173 shs
• Market Capitalization: $3.70 billion
• P/E Ratio: 46.50
• Dividend Yield: N/A
• Price Target: $140.25
• Consensus Rating: Buy

Integer Stock Analysis - MarketRank™

Integer scored higher than 84% of companies evaluated by MarketBeat, and ranked 180th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Integer has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Integer has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 10.65%

Earnings Growth

Earnings for Integer are expected to grow by 10.65% in the coming year, from $6.01 to $6.65 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Integer is 46.58, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.56.

Price to Earnings Ratio vs. Sector

The P/E ratio of Integer is 46.58, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.27.

Price to Earnings Growth Ratio

Integer has a PEG Ratio of 0.85. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Integer has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.37% of the outstanding shares of Integer have been sold short.

Short Interest Ratio / Days to Cover

Integer has a short interest ratio ("days to cover") of 5.5.

Change versus previous month

Short interest in Integer has recently decreased by 4.29%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Integer does not currently pay a dividend.

Dividend Growth

Integer does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

6.37% of the outstanding shares of Integer have been sold short.

Short Interest Ratio / Days to Cover

Integer has a short interest ratio ("days to cover") of 5.5.

Change versus previous month

Short interest in Integer has recently decreased by 4.29%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.29

News Sentiment

Integer has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Integer this week, compared to 7 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Integer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,825,564.00 in company stock.

Percentage Held by Insiders

Only 2.16% of the stock of Integer is held by insiders.

Percentage Held by Institutions

99.29% of the stock of Integer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ITGR Stock Analysis - Frequently Asked Questions

How have ITGR shares performed this year?

Integer's stock was trading at $132.52 at the beginning of the year. Since then, ITGR shares have decreased by 20.2% and is now trading at $105.7350.

How were Integer's earnings last quarter?

Integer Holdings Corporation (NYSE:ITGR) issued its earnings results on Thursday, July, 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing analysts' consensus estimates of $1.57 by $0.02. The firm's revenue was up 11.4% on a year-over-year basis.
Read the conference call transcript.

Who are Integer's major shareholders?

Integer's top institutional shareholders include State Street Corp (3.79%), Ameriprise Financial Inc. (3.69%), Viking Global Investors LP (3.67%) and Alliancebernstein L.P. (3.16%). Insiders that own company stock include Joseph W Dziedzic, Martin C Maxwell, Donald J Spence, James F Hinrichs, John A Harris, Andrew Senn, Tommy P Thomas and Jean M Hobby.
View institutional ownership trends.

How do I buy shares of Integer?

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Integer investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Palo Alto Networks (PANW).

Company Calendar

• Last Earnings: 7/24/2025
• Today: 9/03/2025
• Next Earnings (Estimated): 10/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:ITGR
• Previous Symbol: NASDAQ:ITGR
• CIK: 1114483
• Web: www.integer.net
• Phone: (214) 618-5243
• Fax: 716-759-5654
• Employees: 11,000
• Year Founded: 1940

Price Target and Rating

• Average Price Target for Integer: $140.25
• High Price Target: $145.00
• Low Price Target: $132.00
• Potential Upside/Downside: +31.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.27
• Trailing P/E Ratio: 46.90
• Forward P/E Ratio: 17.71
• P/E Growth: 0.85
• Net Income: $119.90 million
• Net Margins: 4.61%
• Pretax Margin: 6.42%
• Return on Equity: 12.27%
• Return on Assets: 6.23%

Debt

• Debt-to-Equity Ratio: 0.72
• Current Ratio: 3.41
• Quick Ratio: 2.18

Sales & Book Value

• Annual Sales: $1.79 billion
• Price / Sales: 2.08
• Cash Flow: $8.79 per share
• Price / Cash Flow: 12.11
• Book Value: $48.62 per share
• Price / Book: 2.19

Miscellaneous

• Outstanding Shares: 35,035,000
• Free Float: 34,278,000
• Market Cap: $3.73 billion
• Optionable: Optionable
• Beta: 1.03